ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001149.1|Brabantamide_1 # 1 # 1314 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.635	BGC0001149.1|Brabantamide_1 	1	1314	+	Loose	600	72.7886	rgt1438	30.18	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCTGATCAGGGAGGCCTACCACCGCAAGATCACTCTGGAGGGAACCTTAATGCATGTGATCATTACGGCCGTCGGCTCAGCCGGTGACGTTCATCCATTTGTCGGCATCGGCCGCACGCTCGTGGCTCGCGGGCATCGGGTCACGTTTTGCGCCAGCGCGGCGTTCGCGCCGTTGATCGAGCGCTGTGGTTTCAACTTCTTGCCATTGGGTACCCGTGAGGAATATGACGAGGTCATGGCTGACCCGGCGTTGTGGCATCCGCGCACGTCATTGCCCACCCTCTGGAAAACCATCGCCAGCACCCTGCGCGAACAGTACCGGCTGCTGGAACAGGCCTGTGACGACGAAACGGTCATGCTGGGGTCCTTGTGGGCATTCTCCGCGCGCCTGCTGCAGGAGAAACACGGTATCCCGCTGGTCACCGCGCAGGTGTCGCCGTTCGGTTTCTGGTCGGCCGCCGCGCCCGCGACCCATCCACCAGGCGCCAACCTGCCGGCCTTCGTACCCTATCCCGTGAAACGGCTGCTGCTGGGGGTGATCGAACGGGCATTTCTCGACCGGGTCATGGCCCCGGAGCTCAACAGCTTCCGCCAGGAACTGGGGCTCGCGCCGACCAAACGCATTATCAGCCAATGGATTTCCTCGCCTGATCGGGTGCTGGGGCTGTTTCCAGACTGGTTCGCCCCCGTACAACACGACTGGCCTGCCCAGACCGTCCTGACTGGTTTCCCGTTGTTCGATGAGTCCGGGCTCCAACCGCTCGACGCCGAACTGGAAGACTTCCTGAACGAGGCTTCACCGGTGGTGTTTACCCCGGGTTCGACCATGGTCAATGGCGAGCAATATTTCACCGCGGCGGTTCAGGCACTGAAATTGGTCAACCGTCGCGGCGTGTTTCTGACCAGCCAGCCGGTGGATCCTTCAGTGTCCAGCGAAGGCAGGATTCTGGTACGGCGCTACGTGCCGATGAGTCGCATCCTGCCCCACAGCGCGGCGCTGGTGCATCACGGTGGTGTCGGGACCACGGCCCTGGCCATGGCCGCCGGCGTGCCGCAGATCGCCACGCCATTCGCTCACGATCAGTTCGACAACGCCGCACGAATGGAGCGCCTGGGTTGTGGCTTGCGGGTCTTCCCGCCCGCCTCCGCCGAGTCGCTGGCGGCGGCACTGGACAAGGTCTTGAACAGCCAGGAAGTACGCGCCAGTTGCGACCGCTACCGCACACTGATTCCGAGCGGTGACAGTGCCAGTGAAGCAGCGGCCCTGCAGATCGAGGCACTCGCCCGGACTGCCAGGTCACGCGCAGCCTAA	MLIREAYHRKITLEGTLMHVIITAVGSAGDVHPFVGIGRTLVARGHRVTFCASAAFAPLIERCGFNFLPLGTREEYDEVMADPALWHPRTSLPTLWKTIASTLREQYRLLEQACDDETVMLGSLWAFSARLLQEKHGIPLVTAQVSPFGFWSAAAPATHPPGANLPAFVPYPVKRLLLGVIERAFLDRVMAPELNSFRQELGLAPTKRIISQWISSPDRVLGLFPDWFAPVQHDWPAQTVLTGFPLFDESGLQPLDAELEDFLNEASPVVFTPGSTMVNGEQYFTAAVQALKLVNRRGVFLTSQPVDPSVSSEGRILVRRYVPMSRILPHSAALVHHGGVGTTALAMAAGVPQIATPFAHDQFDNAARMERLGCGLRVFPPASAESLAAALDKVLNSQEVRASCDRYRTLIPSGDSASEAAALQIEALARTARSRAA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	106.33	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1221	rifampin; rifaximin; rifabutin; rifapentine
BGC0001149.1|Brabantamide_2 # 1410 # 8675 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.641	BGC0001149.1|Brabantamide_2 	1410	8675	+	Loose	1000	144.821	almE	27.83	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGACGCGCTCTACCCGCTGACTGCCCCACAACTGGACATCTGGTTGGATCAAGTGCTGCACGGCGACAGCCCGCTGTACAACATAGGCGGGTATGCCTGCATCAACGGTCCGGTCGACGCCGCAAGGTTGAAACAAGCCATCGACCACGTGGTCAGTCGCCACGACGCCCTGCGCATTCAACTGGTGCCCGGCTCGGCGGATCATCCCCTGCCGCGGCAGCGCTTCCTGGAATCGGCCAGCGCACCGCTGACCTTGCACGATGTATCGGCAGAAGCCGATCCGCAGGCCAGCGCCCTGGCCCTGCTGCAAGTCAACCTGCAAACGCCGTTTTCCTTTGACGGCGGATTGCTGTTTCGCACGGACCTGATCAAGGTTCGCGACGACCTCCATTACTTTTTCGTCAACGGCCACCACCTGATCATCGACGGCTGGTCCTTCGCCATGATCGGCCGGGCGATCAGCGAGGCGTATACCGCCGCGCTGGATCCGGCGGAAACGCCACTGCCGGCGCCGACCTACCAGGCGTATGTCGACCAGCAGCGGAACGCCAAGAACTCACCTGCCTTCCAGCGACAGCGCCAGTACTGGCTGGACAAATACCGCAGCGTGCCCGAACCCCTGCTCGCGCCCCGTCACCCCGGTCGATTCGAGCAACGCCTGGCCCCCAGCCAGAACCACGCCTGGCGCTTGCCGCGGGCGCTCTACGATCGTCTCGGTGAACGGGCCAAGGCCTGCGGACAGGCGACGGTTTTCCACGCCATGCTGGGCCTGCTTTACGCATACTTCGCGCGGGTTGCGCAACGCGATGAGATCGTGATCGGCATGCCGATCCTCAACCGCGCCAATGCCGCACACAAGGCCACGGTCGGCCTGTTCGTCGGCATGAGTCCGGTACGCCTGAGCCTGGGCACCGAACTGAGTTTCAGCGAGTTGGTCGCCAGGATCGCCCTGACACTCAAGCAGGACTATCGCCATCAACGCTATCCCTTGAGCGAACTGAACCGTGAGCTGGGCCTGCAGAACCAGGGCCGGCGGCAATTGTTCGACCTGGTGGTGTCCTACGAACAAGACCAGGACACCTGGTACGGGGCCGCGCCCGCCCAACCGGTCAAGCTCAGCAACGGCTACGAACAGATGCCCCTGGCGATGCACATTCGCGAAGCCGCGCCGGACGACGATGTGTGGATGCACTTCATCTACAACGAGGCCTGGTTCGACGCGGCGCAGATCGAGGCCTTGCAACAGCGCTTCATGACCGCACTGCACGGTGTGGTCGATGATTTCGACGTGCCGGTCAAGGCCCTCGACATCATGCCGCCGGTCGAGCGCTACCGGGTGGCGAATGAATGGAACCACACCCCTGTCGACTACCCCAGGGACGTACTGCTTCATCAACTGATCGAAAACCAGGTCGCCGCACGCCCCGAAGCCACAGCGGTGCGTTTCGAAGACCGGACGCTGACCTACGACGAACTGAATCGACGGGCCAATCAGGTGGCCCACGCCCTGCTCGAAACCGGTATCGGCCCCGACGCACGGGTCGCCATTTGCCTGGAACGCAGCCTGGAAATGGTGGTGGGCCTGCTGGGCATTCTCAAGGCGGGCGGCGCCTACGTGCCCCTGGACCCGGGGTATCCTGCCGACCGCTTGCGCCACATGTTGAGCGACAGTGCCCCCAGCGCCCTGCTGACCACCCGTGTCTTGCTCAGCAGCCTGCCCGCCGTGACGATGCCGGTGCTGTGCCTGGACAGCGACCTCGAGCAGCTGTCCCGCCAACCACAGCACAACCCGGACCCCGTCGCCCAGGGATTGACCCCGCGACACCTGGCCTACGTGATCTACACCTCCGGTTCCACTGGCCTGCCCAAAGGCGTCATGAACCAGCATGACGGGGTGGTGAACCGATTGCTCTGGGCCCGCGACGCCTACCAGGTCGATGAACACAGCCGCGTCCTGCAAAAAACCCCGTTCAGTTTCGACGTGTCCGTCTGGGAGTTCTTCCTGCCGCTGCTCAGTGGCGCGCAACTGGTGGTCGCCGCTCCCGGCGGGCATCAGGACCCTCGCTACCTGCTGGACATCATGGCGAGCGCCGGCATTACCCTGCTGCACTTCGTGCCATCGATGCTGCAGGTCTTCCTCGATCAGGTCACGGCGCAACCATTGCCAGCCTTGAAGAAAGTCCTGTGCAGTGGCGAAGCCTTGCCCTATGCCTTGCAGACGCGTTTTTTCGAGCGCCTGCCAGGGGTACAGTTGCACAACCTCTACGGCCCCACCGAGGCGGCCATCGACGTGACGGCCTGGCAATGCCGACCCGATGTGCACCCAGGCATCGTCCCCATCGGCCGACCGATCGCCAATACCCAGCTGTACATTCTCGACGCCAACCTGCAACTGTTGCCGCCGGGCATCGCCGGCGAGCTTCACATCGGCGGCATCGGCGTCGCGCGGGGCTACTTGAACCGTGAGCAACTGACCGCCGAACGGTTCATCCGCGACCCGTTCCAGGCCGACCCACAGGCGCGCCTGTACAAGACCGGTGACCTGGGTCGCTGGCTGCCCGACGGCAGCATCGAGTACCTGGGCCGCAACGATTTCCAAGTGAAGATCCGTGGCCTGCGTATCGAACTCGGTGAGATCGAAGCACGCCTGGCGGCTTGCGCAGGCGTCAAGGAGGTCGTGGTCATTGCGCGCCAGGAAACCGAAGGCGATGCCTGTCTCAGCGCCTACCTGGTGGGCGAGCCCGGCTGTGTGTTGTCACCCCAGGCCCTGAGTGCAACCTTGCGCCAGCACGTGCCCGACTACATGGTGCCCCGGCACCTGATCCAGCTCGAACAATTGCCCTTGAACGCCAACGGCAAGCTCGACCGCAAGGCCTTGCCGGAACCCGCGCAATCCTTCGGCAGCACCGACACGACGGCGCCGCGCAATGCCCTGGAACAGACACTGGCCGAACTCTGGGCGGACAACCTGCAACGCCCCGTGCCCGGCGTCCACGACAATTACTTCATGCTCGGGGGCGACTCCCTGAAAGTCATCCACCTGCAGATCAAGGCTCGTGAACAAGGGATCGCCCTGACACTGGCACAGGTCTATCAGCACCCGACCATCGCTGAACTGGCCCAGAGCCTGCAGGCGCAGGCCGTCGCGCCGGCGGACCTGTCGCCCTCGGCCCATGTCGCCCCGTTCGCACAGGTGCCGGAGGCGATCCGCCTGGCCAATGAAGGTGAGTTCGAGGACGTTTTTGCCGCCTCGCAACTGCAAGTCGGGATGATCTACCACTCGATGATGCATCCGGATTCGGCGATCTATCACGACATCTTCCGCTACCGCCTGCGCCTGCGCTGGGATCCGCTCGCCTGGGACCGCGCCTGTCGCACGCTGATCCGCCGCCATCCGGCATTGCGCATGTCGTTCGACATCGGCCATGCCGAAACCCCCATGGCCCGGATTCATTCAAGGGTCGAGCCGCCGGTGCAGATCATCGATGCCGTGTCACTGAGCCCTGAAGCACGGGCCCAGGCGATTGCCGCCTACGTGGAGGAGCGCAAGCGCTACCGCGAAGACTGGCAACGGGCGCCGCTGTATCAGTTCTGCGTGTTTGTCGCGGCCCGGGAAATCGATCTGGTGTTGAGTTTCCATCATGCGATTCTCGATGGCTGGAGCGTCGCCACCCTCATGCGTGACCTGATCACGCTCTATACCTCGGAACCCGATACCGACGCACTGCCCGTGCTGACGACCACACCCGCCGACTTTGCCGCCCTGGAGCAGGACGCCATGACGTCCGACGTCCACCGGCACTTCTGGCGCGAATACCTGCACGACGCACCCGCCGCTTCCATGACCAGTTGGGTCTCCGTGGTCACCCCCGACCCGGCCCCACACCGCTCGGCCTGGCGGGAACTGCCCCCGGCCGACCTCGCGCGGCTCGAGGCGTTCTGCCGCGCCCAGGACCTGCCATTGCGCGCGGTCCTGCTGGCCGCCCACGGTTTCGCCCAAGCCATTCTGTCCAACCAGACGGAAGTGTTGTGTGGCGTCATCAGCCATGGTCGGCCGGAATTCGAAGATGCAGCCTCGGTGCTGGGCCTGTTCCTCAATACCCTGCCCATCCGCTTCAGTACCCAGGGCCGCAATTGGCTCGAAGTGATCCGCGCGCTGATCGCCCAGGAGCAACAGGTGTTCGCCCACCGGCGCTATCCGTTCGCCCTGATCCATCGCGAAACCGCCGTGGCCCTGGACGTGGTGTTCAACTACGTCGACTTCTATGTGCTCAAGGACATGCTGGCGCAGGACGAGGAAATCCTCACCGAATGGGACACCACGGAAGCCAGCAACTATGACCTGCTGACCACCGTGGGTCGCCATCCCGCCAACGGCTCGCTGATGCTGAAGATGGACTACTGCACGGCGCGGGTTGCCACCAGCCAGGTCGAGGCCTATGCCGATTACCTGCTGCGCACCCTGGAGCTGATGATCGCCGGGCCCGGTTCCGCGCCGAGCATACCGGCCTGGCTACCTGCCCCCGTCCAAGCCATGCCGACGGCGGTCACGCCAATGCCCCATGACAATCTGTCGTCCTTGTTGCTGGACCGCCTGGCGGGCCACGACGAGCAGATTGCCGTGAGCTTCGAGCAGACCCACTTGTCCTATCGCCAACTGAGCGACACCTGCGCGCAACTGGTGAGTTGGCTGCACCGACAGGGTATCGGCCAGGGCGATCGGGTGGCGATCATGATGCCCCGCTCGCCCGAACTGATCGTTGCCCTGCTCGGCGTCGTGCAGGCCGGCGCGGCGTATGTGCCGATTGACCTGAGCTATCCCCATGAACGTATCCGGCTGATTCTCGAAGACTCCCAGCCGAGCCTGCTGTTGTTCGCCGATGCGTCGGCCACCCTGGCGGCCACGCTGGCCGGCGAGACGGTCAAACGGCATTGGAACGACGTGGCCGCCGGGTTCGACGACGATCTGGCCCGCAGTCATGAGCTGGTCGCCCACATTGCCGCCGGCATCGCCGGCGAAGATAACGCCTACCTGCTCTATACCTCGGGCTCGACGGGACGCCCCAAGGGCGTGGCCATGCCGCACCGTGCACTGACCAATCTGGTGCTCTGGCAGAACCGCCAGCAGAACACCGGCATACCGTTGAAGACACTGCAGTACTCGCCCATTTCGTTCGACGTCTCGTTCCAGGAGATTTTCTCCACGCTATGCGGCGGTGCAGAGCTGGCCATGATCGACGAAGGGCTGCGCTATGACTTCATCCGGCTGCTGAAATTTATCCAGCTGCAAGACATCAATCGGCTGTTCCTGCCCTACGTCGCCTTCCAGGGACTGGCAGAAGTCGCCCAGCAACTCGATCTCCGCCCCGCCTCGCTGCGCCAGATCAGCGTGGCTGGCGAACAGCTGAAAATCACCGCCGAAATCCGCAACCTGCTGGATAGCCTCGACGATTGCCGAGTGGAAAATCACTACGGTCCGACCGAAGCCCATGTGGTCACTCGCCTGAAGCTGGAAGGCGCCGCGGCGTCCTGGCCGAGCATGCCGCCGATTGGCACCGCCATCGATGGGGTCCGCATGCATGTCTTGGATGCCACAGGCAACGCCTGCCCGGTCGGGGTCACGGGTGACTTGTTCATCGAAGGCATCTGCCTTGCGAACGGCTACTGGAATCGACCTGACCTGACTGACGAACGCTTCATCTATCGTCAGTTGGAGGGCAAGACCCGGCGTCTCTACGAAACCGGCGACATCGGGTTCTACCTGCCTTCGGGCGACCTCGTCTATCAGGGTCGCAGCGACGCGCAGGTGAAGATCCGCGGTTATCGGGTCGAACTGGGGGAAATCGAGGTGGCCATGCTCGGCTCCAGCCGGTTCGGTGCCGACATCCAGCAGGTGGCGGTCATCGACAAGGCGGCTGCGGACGGCGCTCGCTATCTGGTGGGCTTCGTCCAGGCCATGCCGGGGCGCGAGCCGGACCTGGATCAACTCAAGGCCGAGATGCGCCTGGCGCTGCCCGACTACATGGTGCCGAACACCCTGGTCGGCATCGCGCGGATCCCCCTTGGCCCCACCGGCAAGATCGACCGTCGGCAACTGCAGAAGATCGAGGTGCAAACCACCCTGCTGCGTCCGTTCACCGCGCCCAGGAATGCCACGGAAGACTTGTTGCAAGCCTATTGGCAAGAAGCCCTGGACCTGGAAGACATCAGCGTGCACGACAACTTCTTCGAGCTCGGCGGCAATTCGCTCAAGGCCGTGCAACTGGTGGCCATGCTGACCCGGCACCAGGGGCTGGAGCCGTCACTGTCCGACTTCATCCAGGCGCCGACCATTGCCGAATTCGCCCAGGTCCTGCAGCGGACCGACACCGCGTCCTCCGACACCGGCGCACTGGTGGACTTCAAGAATGCCAGCCGGGCGCCGACGCTGTTCCTGGTCCACCCCATCGGTGGGCATGTGCTGTGCTACGCCGCCCTCGCCCGGACCCTCAAGGATCAGGTTCATCTCTACGCGCTGCAAGCGCCAGGGACCTGGGATGCCCGTGAGCCGCTGCAATCGGTGCAGGCCCAGGCCGTTTGCTACGCGGACGCCATTGAACAGGTCGTGCCCCAAGGCCCGTTGAACATCGGCGGCTGGTCCTATGGCGGCATCGTGGCCTATGAGCTGGCGAGCGAGCTACGGCGGCGCGGACGGCGCCTGCACAACGTGTTCCTGCTGGACACCATCGTGCGCGTCAAACAGGGCGAGGTCCGGATAGAACGCAGCGAGTTCATGAACTGGTTCATGTGGGAATTGCTCAGCGGCGACGGCCAGAAGGAATACGACTACCAGGCCCTGGACTTCTCGTGCATGACCGACGAGGACGCCTTCGACGCAATCAAACAGCATGGTATCGAGCAAGGCATCTTCGACAACAACATCAGCCGCACGGCCTTGAAGCAATTGTTCCAGGTGTTCCATGCCAACTGGCAATCGCTGCTGGACTACCGCTTCCCGCCGATGGACCTGCCGATCACGCTGTTCGCCGCGGATGTCGAGTTGCCCGACGTGCTGCAGGCGCCCCATGAGCAGGTGGGCACCGCGTTTCACGACCCGTATCGCGGCTGGCGGACGATTGCGCCCCAGGTTCAGCGGGTGGCCGTGGAAGGCGACCACCTGACCATGATGCGCGAGCCGCACATCGAACGGGTGGGCGACATCATCCGCTCACGAATGGACTCGGCCCGGGCTGCACATGCCGGTGCCCTGGCGGCGTTGGCCTAG	MDALYPLTAPQLDIWLDQVLHGDSPLYNIGGYACINGPVDAARLKQAIDHVVSRHDALRIQLVPGSADHPLPRQRFLESASAPLTLHDVSAEADPQASALALLQVNLQTPFSFDGGLLFRTDLIKVRDDLHYFFVNGHHLIIDGWSFAMIGRAISEAYTAALDPAETPLPAPTYQAYVDQQRNAKNSPAFQRQRQYWLDKYRSVPEPLLAPRHPGRFEQRLAPSQNHAWRLPRALYDRLGERAKACGQATVFHAMLGLLYAYFARVAQRDEIVIGMPILNRANAAHKATVGLFVGMSPVRLSLGTELSFSELVARIALTLKQDYRHQRYPLSELNRELGLQNQGRRQLFDLVVSYEQDQDTWYGAAPAQPVKLSNGYEQMPLAMHIREAAPDDDVWMHFIYNEAWFDAAQIEALQQRFMTALHGVVDDFDVPVKALDIMPPVERYRVANEWNHTPVDYPRDVLLHQLIENQVAARPEATAVRFEDRTLTYDELNRRANQVAHALLETGIGPDARVAICLERSLEMVVGLLGILKAGGAYVPLDPGYPADRLRHMLSDSAPSALLTTRVLLSSLPAVTMPVLCLDSDLEQLSRQPQHNPDPVAQGLTPRHLAYVIYTSGSTGLPKGVMNQHDGVVNRLLWARDAYQVDEHSRVLQKTPFSFDVSVWEFFLPLLSGAQLVVAAPGGHQDPRYLLDIMASAGITLLHFVPSMLQVFLDQVTAQPLPALKKVLCSGEALPYALQTRFFERLPGVQLHNLYGPTEAAIDVTAWQCRPDVHPGIVPIGRPIANTQLYILDANLQLLPPGIAGELHIGGIGVARGYLNREQLTAERFIRDPFQADPQARLYKTGDLGRWLPDGSIEYLGRNDFQVKIRGLRIELGEIEARLAACAGVKEVVVIARQETEGDACLSAYLVGEPGCVLSPQALSATLRQHVPDYMVPRHLIQLEQLPLNANGKLDRKALPEPAQSFGSTDTTAPRNALEQTLAELWADNLQRPVPGVHDNYFMLGGDSLKVIHLQIKAREQGIALTLAQVYQHPTIAELAQSLQAQAVAPADLSPSAHVAPFAQVPEAIRLANEGEFEDVFAASQLQVGMIYHSMMHPDSAIYHDIFRYRLRLRWDPLAWDRACRTLIRRHPALRMSFDIGHAETPMARIHSRVEPPVQIIDAVSLSPEARAQAIAAYVEERKRYREDWQRAPLYQFCVFVAAREIDLVLSFHHAILDGWSVATLMRDLITLYTSEPDTDALPVLTTTPADFAALEQDAMTSDVHRHFWREYLHDAPAASMTSWVSVVTPDPAPHRSAWRELPPADLARLEAFCRAQDLPLRAVLLAAHGFAQAILSNQTEVLCGVISHGRPEFEDAASVLGLFLNTLPIRFSTQGRNWLEVIRALIAQEQQVFAHRRYPFALIHRETAVALDVVFNYVDFYVLKDMLAQDEEILTEWDTTEASNYDLLTTVGRHPANGSLMLKMDYCTARVATSQVEAYADYLLRTLELMIAGPGSAPSIPAWLPAPVQAMPTAVTPMPHDNLSSLLLDRLAGHDEQIAVSFEQTHLSYRQLSDTCAQLVSWLHRQGIGQGDRVAIMMPRSPELIVALLGVVQAGAAYVPIDLSYPHERIRLILEDSQPSLLLFADASATLAATLAGETVKRHWNDVAAGFDDDLARSHELVAHIAAGIAGEDNAYLLYTSGSTGRPKGVAMPHRALTNLVLWQNRQQNTGIPLKTLQYSPISFDVSFQEIFSTLCGGAELAMIDEGLRYDFIRLLKFIQLQDINRLFLPYVAFQGLAEVAQQLDLRPASLRQISVAGEQLKITAEIRNLLDSLDDCRVENHYGPTEAHVVTRLKLEGAAASWPSMPPIGTAIDGVRMHVLDATGNACPVGVTGDLFIEGICLANGYWNRPDLTDERFIYRQLEGKTRRLYETGDIGFYLPSGDLVYQGRSDAQVKIRGYRVELGEIEVAMLGSSRFGADIQQVAVIDKAAADGARYLVGFVQAMPGREPDLDQLKAEMRLALPDYMVPNTLVGIARIPLGPTGKIDRRQLQKIEVQTTLLRPFTAPRNATEDLLQAYWQEALDLEDISVHDNFFELGGNSLKAVQLVAMLTRHQGLEPSLSDFIQAPTIAEFAQVLQRTDTASSDTGALVDFKNASRAPTLFLVHPIGGHVLCYAALARTLKDQVHLYALQAPGTWDAREPLQSVQAQAVCYADAIEQVVPQGPLNIGGWSYGGIVAYELASELRRRGRRLHNVFLLDTIVRVKQGEVRIERSEFMNWFMWELLSGDGQKEYDYQALDFSCMTDEDAFDAIKQHGIEQGIFDNNISRTALKQLFQVFHANWQSLLDYRFPPMDLPITLFAADVELPDVLQAPHEQVGTAFHDPYRGWRTIAPQVQRVAVEGDHLTMMREPHIERVGDIIRSRMDSARAAHAGALAALA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	435.43	gnl|BL_ORD_ID|4935|hsp_num:0	5928			117	1635	colistin A; colistin B
BGC0001149.1|Brabantamide_3 # 8766 # 9953 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.641	BGC0001149.1|Brabantamide_3 	8766	9953	+	Loose	700	76.2554	tet(47)	24.39	3004613	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGACAGAACCCAGGAAAGCCATCGTGGCGGGCGCCGGTATCGGTGGACTGACCGCGGCCATCGCCCTGCAACGAGCGGGCTGGCAGGTCAAGGTCTTCGAAGCGGCCCAGACGCTGCGCACCGGTGGCACCGGTTTGTCCATCATGGCCAATGCCATGGCGGCGCTGCATTCGATCGATGCCCATGTGCCGGTGGAACAGGCGGGCCAGGCGATCCGACAGTTTTTCTTCAAGAAGCACAACGGCCAGCCCATTACCCGCATGCCGATCCACGAGGTGGGCGAGCAACTGGGCCATCCCAATGTGAATATCCAACGCCCGTTGCTGCTGCGCGCCCTGGCCCAGCAGCTCGCACCCGACAGCCTGACCACCGGGTTGCGTTGCGTGGGCTACAGCCATCGCCCGGATGGCGTGACCGTACAGTTCGAAGATGGCAGCACCCAAGAGGCTGACCTGCTGATCGGCGCCGATGGCCTGAATTCGGTCATCCGCCAGCAGATGCTCGGTGAAACACCTACACGCCCTTCGGGCTATATCGCCTGGCTCGCGGTAACGCCGTTGCGCCATCCGGTGATGACCGAAGGCTACGTGGCCCATTACTGGGGGCGCGGCAAGCGGTTCGGGTTGTGTGACGTGGGGGATGGCCATGCGTACTGGTGGGGAACCTGCAACCGCGCCAATGCGGCGGATGACGCCTTGAACGTCAGTAAACAGGAAGTGCTCGGCGCCTATGCCGGCTGGGCACCGGAAGTCGTTGCCGCCATCGAGGCCACGCCCGAGAGCGCCCTGCTGAAAATGCATGCCCGGGATCGTCATCCCGTGAAGCAATGTCGCGACGGGCACGTGGTGCTGCTGGGCGACGCCGCTCACCCGATGCTGCCCAGCCTGGGCCAGGGTGCGGCACAGGCCATCGAGGATGCCGTGGTGCTTGCCAATTGCCTGGCACAGACGCCGGATCTAGGCAGCGCGTTGGCGCATTACCAGGCGTATCGACTTCCCCGGGCCAACGGGATCGTCAATGCCGCACGCTTCATGAGCGGCATCGAACAGGCCGAATCGACATTCGCCTGCTGGGCCCGGGAATGGTACTTCCGCCTGACGCCACAGAGCAGCTGGCGCAAAAAGAACCTCGACATCCTGTCGTTCAAGCCCGGCCTACAACCGGTCGCAGCCTACGTCAATGACTGA	MTEPRKAIVAGAGIGGLTAAIALQRAGWQVKVFEAAQTLRTGGTGLSIMANAMAALHSIDAHVPVEQAGQAIRQFFFKKHNGQPITRMPIHEVGEQLGHPNVNIQRPLLLRALAQQLAPDSLTTGLRCVGYSHRPDGVTVQFEDGSTQEADLLIGADGLNSVIRQQMLGETPTRPSGYIAWLAVTPLRHPVMTEGYVAHYWGRGKRFGLCDVGDGHAYWWGTCNRANAADDALNVSKQEVLGAYAGWAPEVVAAIEATPESALLKMHARDRHPVKQCRDGHVVLLGDAAHPMLPSLGQGAAQAIEDAVVLANCLAQTPDLGSALAHYQAYRLPRANGIVNAARFMSGIEQAESTFACWAREWYFRLTPQSSWRKKNLDILSFKPGLQPVAAYVND	MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE	95.18	gnl|BL_ORD_ID|4799|hsp_num:0	3308			84	1047	tetracycline; oxytetracycline
BGC0001149.1|Brabantamide_4 # 10450 # 11277 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.572	BGC0001149.1|Brabantamide_4 	10450	11277	+	Loose	390	28.1054	evgA	36.36	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATCGACATGCGGTTTTTGGAGGTGCGCAAAACACGCACATCTACGCGGAGCTAGGAAAGCTGATTTCAAGTGTCGGACACGAGAGTTTCTTGACCAACATGCACCAACTGATCGAAACATCGGTGCCTGTCAGTCGACTCGAACTGAGTGAGTGGACAATTGACGATGCCCAGGCAACGGTCCTCGATGTGCAGTTGCTCGGGGATGCAGGCCAGCCGAAAAGCCCGCAGATGCAATCCGTCTGCCCTACCACTGCAATACAGCGCAACGACCACCCCCTGGTGAAACGGGTCCTGGAAGTGGACGACGCCCTGCTGATCCACCTGGGCGCACGGATGAAGAACGAAAGAGACAACAACTGCCTGGGTACTTCCCATCAATGCAGCCTGATTTCGCGCAAGGGCAATCGTCGCTGCGTGATCTCGTTGCACCGTCCCCAGGCACAGCGCGACTTTTCCCTGCAGGAACTGTCCTTTTTGAAATACCTCTCCGAGACGCTGTTGCCCTTGGGCGAGCGCCATGCCCATCTCAATCGGCAGTCGTCTATCAGGAGCCCGGGCAGTTCTACCTCGCATCCGCTGAACATTGCCGACCAGACACAGCTGCAACGGGATTTCGATGAGCGATTGAGCCCGTGTGACGTGACCCTTTCGGTGCGGGAAAAAGAGGTCTGCCTGGGGCTCCTGGCCGGCGGTACCGTCCCGGAGATAGCAGAAAAGCTGCAAGTCAAAAACAGTTCCATCGAAACCTACCTCAAACGCGCCGCCGCCAAGCTTGGCGTCAGCGGACGGCATGGGCTGGCGAAATGGATGATCGGATCCTGA	MNRHAVFGGAQNTHIYAELGKLISSVGHESFLTNMHQLIETSVPVSRLELSEWTIDDAQATVLDVQLLGDAGQPKSPQMQSVCPTTAIQRNDHPLVKRVLEVDDALLIHLGARMKNERDNNCLGTSHQCSLISRKGNRRCVISLHRPQAQRDFSLQELSFLKYLSETLLPLGERHAHLNRQSSIRSPGSSTSHPLNIADQTQLQRDFDERLSPCDVTLSVREKEVCLGLLAGGTVPEIAEKLQVKNSSIETYLKRAAAKLGVSGRHGLAKWMIGS	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	134.80	gnl|BL_ORD_ID|936|hsp_num:0	1015			426	558	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001149.1|Brabantamide_5 # 11362 # 12786 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.636	BGC0001149.1|Brabantamide_5 	11362	12786	+	Loose	850	608.601	OprM	67.24	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTAAACTCCTGAGTCCCTTGACGGCCGCTACACTCCTGCTCGGCGGTTGCTCGCTGATCCCGGACTACCAGCGCCCCGATGCCCCCGTCGCCGCGCAATACCCCCAGACATCCGCCTACGCCCCGGCCCTGGTGGGCCCCGCCGCAGCCGATCAGGGCTGGCGAGACCTGTTCCATGATCCGGCGCTGCAGCAACTCATCGAGAGCGCATTGGTCAACAACCGCGACTTGCGCGTGGCGGCCCTGAACGTCGAGGCCTACCAGGCGCAATACCGGATCCAGCGCGCAGACATCTTCCCGGCGATCAGTGCCAACGGCACCGGCTCGCGCCAGCGGCTACCGAGCAGCCTGACGCAAACCGGCAAATCGGCCATCAGCAGCTCGTACTCCACCACGTTGGGCATCAGCGCCTATGAGCTGGACCTGTTCGGACGCATACGCAGCCTCAGCGACCAGGCGTCCCTCACCTATCTGTCCAGCGAAGAAGCCCGCCGCAGCACCCAGTTGAGCCTGGTGGGCAGTGTCGCCAGTGCCTACCTGACCTGGCGTGCCGACCAGGAATTACTGGCACTGACCCAGGACACGCTGCAGTCCTATGAACAAAGCCTGCGCCTGACAGAACGAAGCAATCAGGTGGGGACGGCCTCGGCCCTGGCCCTGAGTCAGTCACGCACCTCGGTGGAAGACGCCAGGGCCCGCCTGGCCCAGTTCCAGCGCCAGGTCGCCCAGGACTTCAACAATCTCACCTTGCTGGTGGGCACTTCGATAGCCGATGACCTGCCCGCTCGCCCCCTGGCCTCCGAGCTGCTGAGCGAGGTACCGGCCGGCCTGCCTTCGGACCTGTTGCAACGCCGCCCGGATGTGCTCGAAGCCGAGTACCTGCTGCAAGCAGCCAACGCCAATATCGGCGCGGCCCGTGCCGCCTTCTTCCCGAGCATCAGCCTGACCGCCAACGCCGGCACCTCGAGTAACGAGTTGTCCGGGCTGTTCAAGAGCGGGTCGGGCAGTTGGTTGTTCCAGCCCCAGATCAACCTGCCGATTTTCAATGCCGGCAGCCTTCGGGCGAGCCTGAACTATTCGAAAATCCAGAAGGATATCCGCGTCTCCCAGTACGAAAAATCGATCCAGACGGCTTTCCGGGAAGTCTCCGATGGTCTGGCGGCGCGCAAGACCTACAAAGAACAACTGGTCGCGCAGACCGATCTGGTACAAGCCAACCAGGACTACTACAGGCTGGCGGAGCGTCGCTATCGCATCGGCGTCGACAGCAGCCTGACGTTCCTCGATGCACAACGCTCGCTGTTCAGCGCCCGGCAGACCCTTATCGTCGATCGGCTGTCGCAACTGCTCGCCGAGGTCAATCTGTACAAGGCGCTGGGTGGGGGTTGGGTCGAACGCACAAACACCATGACTGTGAGGTGA	MRKLLSPLTAATLLLGGCSLIPDYQRPDAPVAAQYPQTSAYAPALVGPAAADQGWRDLFHDPALQQLIESALVNNRDLRVAALNVEAYQAQYRIQRADIFPAISANGTGSRQRLPSSLTQTGKSAISSSYSTTLGISAYELDLFGRIRSLSDQASLTYLSSEEARRSTQLSLVGSVASAYLTWRADQELLALTQDTLQSYEQSLRLTERSNQVGTASALALSQSRTSVEDARARLAQFQRQVAQDFNNLTLLVGTSIADDLPARPLASELLSEVPAGLPSDLLQRRPDVLEAEYLLQAANANIGAARAAFFPSISLTANAGTSSNELSGLFKSGSGSWLFQPQINLPIFNAGSLRASLNYSKIQKDIRVSQYEKSIQTAFREVSDGLAARKTYKEQLVAQTDLVQANQDYYRLAERRYRIGVDSSLTFLDAQRSLFSARQTLIVDRLSQLLAEVNLYKALGGGWVERTNTMTVR	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	97.73	gnl|BL_ORD_ID|2355|hsp_num:0	1305			0	1401	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
